Ageless
One of the broadest compounded storefronts on the board — GLP-1, NAD+, sermorelin, TRT and more under one roof, in both injectable and oral routes, on low headline pricing (semaglutide $119/mo, tirzepatide $169/mo) — offset by a compounded-only catalog and an undisclosed state list.
- Semaglutide
- $119/mo
- Tirzepatide
- $169/mo
- Coverage
- Varies by state
- Brand-name
- Compounded only
Weigh Ageless against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Ageless dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.
Factor breakdown
Each of the six graded dimensions. See the methodology.
Strengths
- Unusually broad compounded menu — GLP-1, NAD+, sermorelin, TRT, LDN and more, in both injectable and oral formats
- Low headline GLP-1 pricing — semaglutide $119/mo, tirzepatide $169/mo — no insurance, with Klarna/Affirm financing
- Fully online: licensed-clinician review and discreet delivery, with upfront compounded/not-FDA disclosures
- Oral routes available (drops and troches), not injection-only
Where it loses points
- Everything is compounded and not FDA-approved — not equivalent to brand Wegovy/Ozempic/Zepbound
- Oral GLP-1 drops and troches lack robust absorption/efficacy evidence versus injectables
- No published state-availability list and no named legal entity or medical group
- Thin public track record, and advertised prices are floors set after clinical review
Bottom line — Grade B
Best for: Patients who want the widest compounded menu — GLP-1 plus NAD+, sermorelin and TRT, injectable or oral — from one fully-online storefront, and who don't need brand-name access or a published state list.
Ranked #24 of 34 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.
Compare with other providers
All 34 providers graded on the same six dimensions.
Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
High-disclosure, high-oversight compounded program with the cleanest verification signals.
The widest formulation spread on the board — oral/sublingual routes plus standard injection.
Lowest semaglutide sticker on the board ($93) paired with some brand-name access and LegitScript verification.
An established pharmacy operator with steady mid-market pricing and a broad catalog.
Bottom-quartile pricing on both molecules under one flat membership, shipped free nationwide — a strong-value pick sitting just behind the top tier.
Sub-$100 semaglutide and $149 tirzepatide — both molecules, verified and nationwide.
A low-entry compounded tirzepatide program (from $149 microdose) that reaches all 50 states and keeps a brand-name Ozempic path open — a rare combination this far up the value tier.
A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.
A physician-led telehealth under board-certified founder Dr. John Diaz with a broad GLP-1 menu — compounded semaglutide and tirzepatide by injection or oral capsule, plus a brand-name lane and microdosing — on transparent all-inclusive pricing to all 50 states.
The cheapest both-molecule pairing on the board ($100/$133) from a LegitScript-verified operator.
Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.
Mid-value both-molecule pricing ($130/$163), verified, and nationwide.
A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.
A LegitScript-certified, HIPAA telehealth with one of the deepest published catalogs on the board — compounded semaglutide and tirzepatide (oral and microdosed routes included) alongside PT-141, intranasal NAD+, and a long recovery/GH peptide bench — with compounded GLP-1 starting from $49/mo on an annual plan.
Mid-market pricing offset by brand-name access and LegitScript verification, all 50 states.
Among the lowest compounded-semaglutide pricing, with some brand-name access.
Tight both-molecule spread ($133/$166), verified and nationwide.
Cheap semaglutide ($119) but a steeper tirzepatide step-up ($229); verified, nationwide.
Round mid-market pricing ($149/$199), verified and available nationwide.
Low both-molecule pricing ($117/$159) and verified — but only 36 states.
Among the cheapest both-molecule pairings ($99/$139), nationwide — but not LegitScript-listed.
A both-molecule compounded program that publishes its prices up front — semaglutide $199/mo, tirzepatide $299/mo — across a 50-state clinician network, with an optional coaching-plus-labs membership and a NAD+/microdosing menu on the side.
Round-$100 semaglutide nationwide, though tirzepatide runs $175 and it isn't verified.
Verified and nationwide, but priced in the upper-mid band ($152/$246).
Aggressive identical pricing on both molecules, wrapped in a coaching-first program.
Low-ish both-molecule pricing ($117/$196), nationwide — but unverified.
Mid-value both-molecule pricing ($135/$199), nationwide, though not verified.
One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.
Mass-market app-first program with nationwide reach and consumer-grade polish.
Both molecules across 40 states, but upper-mid pricing and no verification listing.
A heavyweight platform with brand-name access — but opaque compounded pricing drags its score.
A flat-fee compounded pioneer — simple, but priced at the higher end of the board now.
Pricing/verification reflect Ageless's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Ageless's site. Not medical advice; see our disclosure.